Anxiety disorder. Anxiety disorder due to known physiological condition
Conditions
Interventions
Intervention 1: Intervention group:For 2 months, in addition to their main treatment (fluoxetine syrup in the first week with a dose of 2.5 cc daily and a dose of 5 cc daily from the second week), the
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
9 Years to 14 Years
Inclusion criteria
Inclusion criteria: Age 9-14 years Children with anxiety disorders based on psychiatrist diagnosis and DSM-5 criteria New case
Exclusion criteria
Exclusion criteria: Having accompanying mood disorder - psychotic disorder - pervasive developmental disorder Receive any type of psychotherapy Taking psychiatric medications other than SSRIs History of complications and drug sensitivity History of seizures Lack of consent of the patient or legal guardian during the plan Mental and physical retardation In case of any concomitant medical disorder such as IP, autism, epilepsy Having physical diseases such as liver disease, heart disease, kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety disorder score. Timepoint: Beginning of the study and 8 weeks after the start of the intervention. Method of measurement: Anxiety questionnaire for children and adolescents (YAM-5).;Anxiety severity based on CGAS. Timepoint: Beginning of the study and 8 weeks after the start of the intervention. Method of measurement: Children Global Assessment Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactfiroozeh derakhshanpoor
Gorgan University of Medical Sciences
Outcome results
None listed